The concentrations of three cytokines were 1.7 to 72.8-fold higher (p<0.0012) in patients with either dry AMD [CXCL6 (p = 0.00067)] and/or treated wet AMD [CXCL5 (p = 0.00099), CXCL6 (p = 0.00067), MIG/CXCL9 (p = 0.00019)] than in the healthy controls, with significant intergroup differences being registered after the application of the Bonferroni correction (Fig 2, Table 3). This evidence concerns the gene CXCL5 and dry age related macular degeneration.